These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6753508)

  • 21. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 23. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of 5-hydroxytryptamine and some beta-adrenolytic compounds on adenylylcyclase in rabbit brain in vitro.
    Kocur J; Jurkowski A; Kedziora J; Czernicki J; Kedziora H
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):113-7. PubMed ID: 1712
    [No Abstract]   [Full Text] [Related]  

  • 26. 125I-LSD: a high sensitivity ligand for serotonin receptors.
    Hartig PR; Kadan MJ; Evans MJ; Krohn AM
    Eur J Pharmacol; 1983 May; 89(3-4):321-2. PubMed ID: 6873167
    [No Abstract]   [Full Text] [Related]  

  • 27. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
    Purohit A; Herrick-Davis K; Teitler M
    Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands.
    el Ahmad Y; Laurent E; Maillet P; Talab A; Teste JF; Dokhan R; Tran G; Ollivier R
    J Med Chem; 1997 Mar; 40(6):952-60. PubMed ID: 9083484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis.
    Penington NJ; Fox AP
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1160-5. PubMed ID: 8014859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT1A and D-2 receptor affinity of o-methoxyphenylpiperazine derivatives with terminal benzamide fragment on N-4 alkyl chain. 2.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Lograno MD; Daniele E; Govoni S
    Farmaco; 1995; 50(7-8):505-10. PubMed ID: 7669188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.
    Parker MA; Marona-Lewicka D; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1998 Dec; 41(26):5148-9. PubMed ID: 9857084
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
    Plassat JL; Amlaiky N; Hen R
    Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Central serotonin receptors].
    Fillion G
    Pathol Biol (Paris); 1985 Apr; 33(4):221-6. PubMed ID: 2861595
    [No Abstract]   [Full Text] [Related]  

  • 36. Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding site.
    Boess FG; Monsma FJ; Bourson A; Zwingelstein C; Sleight AJ
    Ann N Y Acad Sci; 1998 Dec; 861():242-3. PubMed ID: 9928266
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo receptor binding: attempts to improve specific/non-specific ratios.
    Niehoff DL; Palacios JM; Kuhar MJ
    Life Sci; 1979 Sep; 25(10):819-26. PubMed ID: 491833
    [No Abstract]   [Full Text] [Related]  

  • 38. Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone.
    Shenker A; Maayani S; Weinstein H; Green JP
    Eur J Pharmacol; 1985 Mar; 109(3):427-9. PubMed ID: 3987810
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin receptor localization in rat brain by light microscopic autoradiography.
    Young WS; Kuhar MJ
    Eur J Pharmacol; 1980 Mar; 62(2-3):237-9. PubMed ID: 7379844
    [No Abstract]   [Full Text] [Related]  

  • 40. 3H-serotonin binding sites: pharmacological and species differences.
    Nelson DL; Schnellmann R; Smit M
    Adv Biochem Psychopharmacol; 1983; 36():103-14. PubMed ID: 6134434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.